These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

897 related items for PubMed ID: 13679853

  • 1. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X, Giap C, Lazo JS, Prochownik EV.
    Oncogene; 2003 Sep 18; 22(40):6151-9. PubMed ID: 13679853
    [Abstract] [Full Text] [Related]

  • 2. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K, Anand G, Yin X, Grove L, Prochownik EV.
    Oncogene; 1998 Mar 05; 16(9):1149-59. PubMed ID: 9528857
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
    Wu S, Peña A, Korcz A, Soprano DR, Soprano KJ.
    Oncogene; 1996 Feb 01; 12(3):621-9. PubMed ID: 8637719
    [Abstract] [Full Text] [Related]

  • 4. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B, Larsson LG.
    Oncogene; 1999 May 13; 18(19):2955-66. PubMed ID: 10378692
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
    Marchetti A, Abril-Marti M, Illi B, Cesareni G, Nasi S.
    J Mol Biol; 1995 May 05; 248(3):541-50. PubMed ID: 7752223
    [Abstract] [Full Text] [Related]

  • 6. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
    Davis LJ, Halazonetis TD.
    Oncogene; 1993 Jan 05; 8(1):125-32. PubMed ID: 8423990
    [Abstract] [Full Text] [Related]

  • 7. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
    Crouch DH, Fisher F, Clark W, Jayaraman PS, Goding CR, Gillespie DA.
    Oncogene; 1993 Jul 05; 8(7):1849-55. PubMed ID: 8510929
    [Abstract] [Full Text] [Related]

  • 8. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.
    Lavigne P, Crump MP, Gagné SM, Hodges RS, Kay CM, Sykes BD.
    J Mol Biol; 1998 Aug 07; 281(1):165-81. PubMed ID: 9680483
    [Abstract] [Full Text] [Related]

  • 9. Lack of transcriptional repression by max homodimers.
    Yin X, Grove L, Prochownik EV.
    Oncogene; 1998 May 07; 16(20):2629-37. PubMed ID: 9632139
    [Abstract] [Full Text] [Related]

  • 10. Design and properties of a Myc derivative that efficiently homodimerizes.
    Soucek L, Helmer-Citterich M, Sacco A, Jucker R, Cesareni G, Nasi S.
    Oncogene; 1998 Nov 12; 17(19):2463-72. PubMed ID: 9824157
    [Abstract] [Full Text] [Related]

  • 11. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1.
    Schreiber-Agus N, Chin L, Chen K, Torres R, Thomson CT, Sacchettini JC, DePinho RA.
    Oncogene; 1994 Nov 12; 9(11):3167-77. PubMed ID: 7936639
    [Abstract] [Full Text] [Related]

  • 12. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.
    Reddy CD, Dasgupta P, Saikumar P, Dudek H, Rauscher FJ, Reddy EP.
    Oncogene; 1992 Oct 12; 7(10):2085-92. PubMed ID: 1408152
    [Abstract] [Full Text] [Related]

  • 13. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max.
    Västrik I, Mäkelä TP, Koskinen PJ, Alitalo K.
    Oncogene; 1995 Aug 03; 11(3):553-60. PubMed ID: 7630640
    [Abstract] [Full Text] [Related]

  • 14. Function of the c-Myc oncogenic transcription factor.
    Dang CV, Resar LM, Emison E, Kim S, Li Q, Prescott JE, Wonsey D, Zeller K.
    Exp Cell Res; 1999 Nov 25; 253(1):63-77. PubMed ID: 10579912
    [Abstract] [Full Text] [Related]

  • 15. Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain.
    Crouch DH, Fisher F, La Rocca SA, Goding CR, Gillespie DA.
    Nucleic Acids Res; 2005 Nov 25; 33(16):5235-42. PubMed ID: 16166655
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
    Soucek L, Jucker R, Panacchia L, Ricordy R, Tatò F, Nasi S.
    Cancer Res; 2002 Jun 15; 62(12):3507-10. PubMed ID: 12067996
    [Abstract] [Full Text] [Related]

  • 18. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II.
    Bousset K, Oelgeschläger MH, Henriksson M, Schreek S, Burkhardt H, Litchfield DW, Lüscher-Firzlaff JM, Lüscher B.
    Cell Mol Biol Res; 1994 Jun 15; 40(5-6):501-11. PubMed ID: 7735324
    [Abstract] [Full Text] [Related]

  • 19. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.
    Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, Land H.
    Nature; 1992 Oct 01; 359(6394):423-6. PubMed ID: 1406955
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.